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Introduction 
1.1 Glaucoma 
The word Glaucoma derives from the greek “γλαυκός”, meaning light-blue, with reference 
to characteristic color that is developed by opaque and edematous corneas [1]. Glaucoma 
represents a wide group of irreversible neuro-degenerative diseases characterized by 
progressive reduction of the visual field. Worldwide over 90 million people are affected by 
this disease, which manifests itself in a silent and painless manner but leads to progressive 
loss of sight [2]. Glaucoma occurs predominantly later in life even if some congenital and 
juvenile forms of glaucoma exsists, due to dysgenesis of the outflow system. 
Up to now, since the exact pathogenesis of glaucoma is not fully understood, several risk 
factors, such as elevated intraocular pressure (IOP), age, family history, oxidative stress, 
gender, ethnicity, central corneal thickness, and myopia are associated with this disease[3–
5]. However, out of these, the level of intraocular pressure seems to be related both to the 
optic nerve chronic damage and to the retinal ganglion cell death [6,7]. Indeed, several 
studies in the past, based on a large population, have confirmed that by reducing IOP, we 
can also reduce the glaucoma progression in patients with or w/o elevated IOP.  
The collection of glaucomatous diseases is subdivided into two main subtypes: open angle 
glaucoma (OAG) and angle closure glaucoma (ACG) (Figure 1); in both optic nerve 
degeneration is the clinical outcome. In particular, the OAG besides being the predominant 
pathological form, can occur as high-pressure glaucoma (Primary Open-Angle Glaucoma 
POAG) and low-pressure glaucoma (Normal Tension Glaucoma NTG) [8].  
However, OAG and ACG can have primary or secondary causes, based on absence or 
presence of other inciting factors. Indeed, secondary glaucoma can result from many other 
  
pathologic processes, including 
[3,7].  
 
Fig.1. Representation of OAG 
A) In OAG the major site of resistance to outflow of aqueous humor (HA) is at the 
level. This causes an increase of intra ocular pressure inside the eye
B) In ACG the trabecular meshwork and the
[3] 
 
 
1.2 Eye Anatomy 
The human eye is one of the most comple
anatomically it can be distinguished in three layers 
- The fibrous layer
transmits the light both to the lens and the reti
eye role against infection and structural damage to the deeper parts. The sclera 
the layer rich in collagenous fibres, elastic fibres and fibroblast
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of the oculomotor muscles
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inflammation, tumor, shock, pseudoexfoliati
and AGC.  
.  
 uveoscleral outflow resulted blocked as a result of the iris impairment 
x organs, and is specialized for vision. So, 
(Figure. 2, Panel
 consists of the cornea and the sclera. The cornea refracts and 
na. In addition, 
ning eye shape thanks to 
. Its visible part is covered by the conjunctiva. Cornea 
on, and so on 
 
trabecular meshwork (TM) 
 A): 
it plays a protective 
is 
 which protects the 
the tendons 
  
and sclera are connected at the limbus. The limbus
which includes the Trabecular Meshwork (TM), a cru
the Schlemm’s canal, is
pathway. 
- The vascular layer
choroid. The iris through the control of the pupil size, cont
which reaches the retina; the ciliary body is the site of aqueous production and 
controls both the power and 
layer which provides oxygen and nutrients to the 
- The neural layer
that capture and process light. 
The three transparent structures surrounded by the ocular layers are called the aqueous, 
the vitreous and the lens.
Fig.2: A) Anatomy and schematic representation of the 
union of cornea and sclera: The l
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cial tissue that, together with 
 involved in conventional outflow of aqueous humor 
 of the eye is composed by the iris, the ciliary body and the 
rols the amount of light 
the shape of the lens; and the choroid is a vascular 
inner retinal layers
 of the eye is the retina, a complex, layered structure of neurons 
 
 
human eye layer. B) A schematic representation of the point of 
imbus [9].  
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1.2.1 The Cornea 
The cornea is the most anterior part of the eye, in front of the iris and pupil. Cornea is 
considered the most densely innervated tissue of the body, and most of its nerves are 
sensory nerves, derived from the ophthalmic branch of the trigeminal nerve [10]. This 
tissue is avascular, indeed the branches of the anterior ciliary arteries stop at the limbus 
forming arcades which supply the peripheral cornea.  
Five layers can be distinguished in the human cornea: the epithelium, Bowman’s 
membrane, the lamellar stroma, Desçemet’s membrane and the endothelium. 
The corneal epithelium is extremely impermeable and stable due to the presence of cell 
junctions and it is anchored to the basal lamina. It consists of an outer lipid layer and an 
inner water-mucous layer and is covered by the tear film with protective functions on 
corneal surface from chemical, toxic or foreign body damage, microbial invasion and from 
smoothest out micro-irregularities. Moreover, the corneal epithelium is composed by two-
three layers of superficial cells, two-three layers of wing cells and one layer of basal cells 
[11]. Its cells are renewed every 7–10 days from a pluripotent stem cell population, which 
resides in the palisades of Vogt at the corneoscleral limbus [12]. However, previous studies 
has also identified an oligo potent stem cell population from mice and pig epithelium, 
suggesting that there are niche for corneal stem cells besides the limbus [13] (Figure.2, 
Panel B). 
The Bowman’s layer is separated from epithelium by stroma. Bowman’s layer is 
anacellular zone composed by collagen fibrils network which is responsible for the cornea 
mechanical strength and for its transparency [14].  
The stromal collagen fibrils are surrounded by proteoglycans with an important structural 
function in hydration regulation. The predominant stroma cell type are Keratocytes and 
they play a role in maintaining the stroma organization.  
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The corneal endothelium consists of a single layer of five-seven-sided cuboidal cells with 
little or no self-renewing potential. They secrete the Descemet’s membrane that separates 
the endothelium from the stroma. This elastic membrane is composed of an anterior layer 
with a banded appearance and a posterior layer with an amorphous texture [15].  
The endothelium possesses intracellular and membrane-bound ion transport systems and 
the resulting osmotic gradient produces a net fluid flux from the stroma to the aqueous 
which is essential for the clarity and transparency of the cornea (i.e. deturgescence) [16].  
1.2.2 The Retina  
The retina is the tissue that lines the inner surface of the eye, surrounding the vitreous 
cavity. During embryogenesis, the vertebral retina develops from the optic cup. The latter 
is formed by invagination of the optic vesicle, which is an outgrowth of the embryonic 
forebrain. The inner wall of the optic cup becomes the neural retina while the outer wall 
becomes the retinal pigment epithelium (RPE) [17].  
The neural retina consists of six major classes of neurons: photoreceptors, bipolar cells, 
horizontal cells, amacrine cells and ganglion cells and the Müllerian glia (Figure.3).  
The eyes of most vertebrates contain two types of photoreceptors: rods and cones. In 
humans, rods are approximately 20 times more abundant than cones [18]. The 
photoreceptors are responsible for conversion of light into an electrical signal 
(phototransduction), therefore the membranes of the outer segment discs contain pigments. 
Cones are responsible for colour vision and have pigments with absorption peaks in the 
blue, green or yellow parts of the spectrum (rods pigments have an absorption peak in the 
blue-green part of the spectrum). In humans, about 50% of the cones are located in the 
central 30% of the visual field, roughly corresponding with the macula.  
Histologically, the macula has several layers of ganglion cells unlike peripheral retina 
which has the ganglion cell layer thick only one-cell. The excavation near the center of the 
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macula is called the fovea and it is responsible for sharp central vision. Fovea contains the 
largest concentration of cones in fact, the visual acuity is highest in this region [18].  
The RPE is a monolayer of cuboidal epithelial cells intercalated between the 
photoreceptors and the choriocapillaris.  
At the apical side, the cells of the RPE form long microvilli that are extended between the 
outer segments of rod photoreceptors and its cytoplasm contains numerous pigment (i.e. 
melanin, lipofuscin) granules. The RPE main features include the maintenance of 
photoreceptor function (phagocytosis of photoreceptor wastes, regeneration and synthesis 
of pigments), retinal adhesion, storage and metabolism of vitamin A, the production of 
growth factors necessary for nearby tissues and wound healing after injury or surgery 
[19,20]. In addition, the RPE plays an important role in the blood–retinal barrier (BRB) 
function. Retinal function depends on several factors, including the region of the retina 
being illuminated, the wavelength and the intensity of the light stimulus and the state of 
light adaptation. 
 
Fig.3: The layers of neural retina [21]. 
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1.3 Pathways through the Aqueous humor outflow system 
1.3.1 Aqueous humor functions 
Aqueous humor (AH) is a clear fluid produced by the ciliary body (CB) epithelium 
consisting both of a pigmented ciliary epithelial (PE) cell layer and a non-pigmented 
ciliary epithelial (NPE) cell layer facing the stroma and the posterior chamber of the eye, 
respectively. After, the AH flows from anterior chamber to episcleral veins passing 
through TM (Figure.4). 
AH, wetting the anterior chamber of the eye, provides nutrients and removes waste 
products. In physiological conditions, the balance in aqueous inflow and outflow rate, 
regulates the IOP in order to maintain the shape and related refractive properties of the eye 
[21].  
1.3.2 Conventional or trabecular meshwork outflow pathway 
The AH returns to the venous system thought conventional or trabecular meshwork 
outflow pathway (Figure.4). The TM represents the proximal portion of the aqueous 
outflow system and it has been estimated that this tissue drains  70–90% of AH. TM is 
divided into distinct regions: the uveal meshwork, the corneoscleral meshwork, and the 
Juxtacanalicular region.This latter, is located between the last trabecular lamellae and 
Schlemm's canal (SC) inner wall endothelium. Therefore, AH crosses the SC inner wall 
endothelium to enter SC either through pores or through transcanalicular conduits arising 
from SC endothelium. Moreover, AH can drains out through the uveoscleral pathway 
which includes the ciliary body and other structures [22,23] 
  
Fig.4: Anatomy of healthy eye and aqueous humor drainage pathways [3]
 
1.4 Trabecular meshwork 
The trabecular meshwork (TM
which together with a complex organ system dependent on several tis
working in unison to maintain a homeostatic IOP.
TM structure consists of the inner uveal trabecular meshwork (
corneoscleral trabecular meshwork (
cribriform region. In addition
contains of a TM stem cell populations, below the Schwalbe's line, named the “insert” 
region of the TM.  
The UTM is characterized by 1
by 8–15 trabecular layers, which are thicker than those of the UTM and originate from the 
scleral spur [24]. Each trabecular beam cons
elastin fibers covered by flat cells that rest on a basal lamina rich in collagen type IV and 
laminin [25–27]. The beams rearrange in several layers
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structure and changes depending on TM region. The porous size of the uveal and 
corneoscleral meshworks range in size from 25–75 µm in the proximal regions to 2–15 µm 
in the deeper layers of the corneoscleral meshwork. Moreover, in the outer region (JCT 
region) the fenestrations became more tight with a porosity that ranges between 30 and 
50% [28,29].  
Among the main TM tissue functions, the filtration and the resistance to outflow resistance 
regulation, are recognized. Nevertheless, the differences in cells morphology and function, 
TM cells have a common embryological origin, the neural crest [30].  
The AH drains through the inner TM and thanks to the macrophage-like activity of UTM 
and CTM cells, is clarified by cellular debris derived from shed pigmented epithelia or 
waste materials before reaching the JCT region. Therefore, a defective macrophage 
activity, could be responsible for secondary form of glaucoma [31]. Then, the tight 
fenestrations of the outer TM region (JCT) together with the inner SC cells, work together 
physically and functionally to generate outflow resistance, in order to restrict flow of 
aqueous humor into the lumen of SC and onto the systemic venous system [28]. Indeed, 
both smooth-muscle like and fibroblastic qualities of JCT cells, respectively, allows them 
to regulate the AH outflow contracting the JCT region and SC wall and to regenerate ECM 
proteins every 48 hrs [32,33].  
Moreover, the TM cells, as endothelia, produce large quantities of antithrombotic 
substances like heparin sulfate and tissue-plasminogen activator (tPA) [34], participate in 
antigen presentation and inflammation pathway, producing major histocompatibility 
proteins and a wide array of inflammatory cytokines, respectively [35,36]. This latter 
feature results important after laser trabeculoplasty because the rapid secretion of IL-1α 
and TNFα in response to the injury, stimulates extracellular matrix turnover and debris 
phagocytosis [37].  
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1.5 Primary Open Angle Glaucoma (POAG) 
POAG is a chronic, progressive, and irreversible multifactorial chronic disease, which 
affects a large proportion of the population over the age of 40 years. Glaucoma clinical 
outcome leads to blindness through a neurodegeneration process which extends beyond the 
retina and optic nerve into the visual pathway [38].  
Currently, POAG etiology remains obscure, probably due to the heterogeneous and 
complex nature of the disease, both on a clinical and on a molecular level. In this regard, 
several research work have identified some of risk factors and genetic causes such as 
aging, elevated IOP (≥ 22 mm Hg), race and a positive family history, involved in 
glaucoma onset [39,40].  
Indeed, it has been estimated that the prevalence of glaucoma increases sharply with age, 
probably because its onset may be associated with other age-related diseases such as 
macular degeneration, vascular diseases, obstructive sleep apnea, and so on. Moreover, the 
state of frailty related to aging, depends on the accumulation of health deficits (i.e. 
hypertension, hypotension, diabetes, migraine, obstructive sleep apnea syndrome, 
cataracts, glaucoma) and results in a higher risk for accelerated physical and cognitive 
decline, disability and death [41,42].  
It seems that also race impacts on prevalence of POAG due to differences in exposure to 
geographic, social, behavioral and environmental factors. In particular, the black American 
population is more predisposed to POAG than whites.  
In addition, several epidemiological evidence demonstrated that a positive family history 
of POAG increases its insorgence risk about 2.1 times. Therefore, the development and 
integration of many genetic approaches were used to identify genome regions that are 
associated with both a specific phenotype and specific genetic variants. The first approach 
  
15 
 
to identify chromosomal locations for Mendelian forms of POAG was the Family-based 
genetic linkage analysis which led to the identification of many POAG-associated loci and, 
less often, specific causative genes. So, genetic mutations for POAG have been identified 
in three genes: myocilin (MYOC), optineurin (OPTN), and TANK binding kinase 1 
(TBK1). In addition, the differential expression analysis of mRNA and proteins have added 
to our understanding of human genetic disorders [43–45].  
1.5.1 POAG Pathogenesis  
Back in 1854, Albrecht Von Graefe described the mainly clinical POAG features by the 
triad including IOP, optic disc excavation and laminar lacunation and specific field loss 
[46].  
However, from the last century is known that oxidative stress (OS), inflammation, 
excitotoxicity, vascular impairment and hypoxia, glial dysfunction and altered axonal 
transport are the most pathogenic mechanisms recognized [47–50]. In particular, OS 
appears to play a pivotal role in TM damage in term of a decrease of mitochondrial 
respiratory activity, an inflammatory cytokine release, an impairment of extracellular 
matrix (ECM) components and its turnover, a cellular senescence promotion and 
consequent a loss of its cellularity, and so on [51,52].  
Therefore, an impairment of TM functions leads to outflow resistance and IOP increase, in 
a region known as the juxtacanalicular tissue (JCT) or cribriform region [53].  
As known, TM together with the JCT, the endothelial lining of Schlemm’s canal, the 
collecting channels and the aqueous veins, represent the major drainage structure for 
aqueous humor (AH) i.e. the conventional or trabecular outflow pathways [25]. In 
addition, some fraction of AH flow out from the eyes through an unconventional or 
uveoscleral outflow route [22].  
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So, in a physiological condition, the fluid flows rate across the trabecular outflow 
pathways equals the rate of AH produced by the ciliary body but this balance is subject to 
alteration with age and POAG. Therefore, an “extra” resistance in AH outflow due to 
cellular dysfunction, including the TM, results in elevated IOP [54]. Morphological and 
biochemical alterations of TM common to several patients with POAG have been observed 
including the loss of cells, increased accumulation of extracellular matrix proteins (ECM), 
changes in the cytoskeleton, cellular senescence, and the process of subclinical 
inflammation. In particular, the TM extracellular matrix (ECM) and its turnover play a 
significant role in modulating AH outflow [54–56]. As known, in physiological conditions 
the ECM contains collagens, laminins, elastin, fibronectin, fibrillins, proteoglycans, 
matricellular proteins, etc. However, several previous in vitro studies highlighted that the 
differences in ECM composition of glaucomatous patients, in terms of a decrease in 
hyaluronic acid and an increase in chondroitin sulfate, correlated with flow resistance. 
Moreover, also Grow Factors (i.e. TGFβ-2) and gene expression (i.e. SPARC, MYOC, 
MMPs) are being modulated [57–61] determining an overexpression of various ECM 
components and IOP increase [55,62]. 
Moreover, with regard to RGCs apoptosis, two theories were proposed as final outcome of 
glaucomatous cascade: the mechanical and vascular theories. 
The mechanical theory, as the name implies, supports that the mechanical action of the IOP 
is directly responsible both of optic nerve head compression and the axoplasmic transport 
cessation, thus resulting in apoptosis of RGCs and their axons [63]. However, the limits of 
such hypothesis are related to the lack of this clinical sign in some types of glaucoma (i.e. 
NTG).  
The vascular theory, instead, explains that the RGCs death is caused by insufficient blood 
flow of the optic nerve head due to several issue such as IOP, high blood pressure, 
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vasospasm and so on [5,63]. Indeed, also diseases like obstructive sleep apnea (OSA) and 
diabetes mellitus type 2 (DM2), are linked to vascular failure [64,65] and POAG.  
 
  
  
1.6 Glaucoma diagnosis and treatment 
Since glaucoma has no symptoms in 
specific molecular and physiological disease markers
and complete eye exams, is important to protecting the vision from damage caused by 
glaucoma. Five common tests are crucial to
perimetry, gonioscopy and pachimetry. 
Tonometry measures the pressure within the eye. The range for normal pressure is 12
mm Hg and, usually, more glaucoma cases are diagnosed with pressure exceeding 20mm 
because eye pressure depends on the individual
ophthalmoscopy exam (fundus examination) or optical coherence tomography (OCT), 
because the fundus is the only location where vasculature can be visualized. The fundus i
the anterior face of the eye opposite to the lens and includes: retina, optic nerve, macula 
and fovea (Figure.5). The glaucoma pathologic feature includes the optic nerve head 
“excavated” or “cupped” which results as reduced fovea region vascularization.
Furthermore, viewing the fundus is a great way to undestand the patient’s overall 
vasculature. For example, the ophthalmoscopic exam, allowed to discover pathological 
processes otherwise invisible: endocarditis, disseminated candidemia, CMV in an HIV 
infected patient, and being able to find both diabetes and hypertension.
Fig.5: A view of the healthy human retina seen though an ophthalmoscope
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its early stage, it has not been possible yet 
 [66]. Early diagnosis, with regular 
 detect glaucoma: tonometry, ophthalmoscopy, 
 
. After a preliminary examination, follows 
 
. [67] 
 
to identify 
-22 
s 
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When disease is diagnosed, the exam of visual field, (perimetry exam) and the gonioscopy 
constitute an important step to understand the map of complete field of vision. The 
perimetry exam helps to clarify whether the vision has been affected by glaucoma, when a 
moving light passes peripheral (or side) vision. Gonioscopy exam helps determine wheter 
the irido-corneal angle is open and wide or narrow and closed. During the exam eye drops 
are used to numb the eye. The angle closed and blocked it is a possible sign of angle-
closure, acute glaucoma; but the angle wide or open is a possible sign of open-angle, 
chronic glaucoma. 
Finally, the pachimetry exam is simple, painless and measure the thickness of the cornea 
and it could be help the glaucoma diagnosis because corneal thickness has the potential to 
influence eye pressure state [68–70]. 
As known, up today the IOP is the only modifiable risk of glaucoma, therefore, the first-
line treatment is represented by ocular hypotensive drops with or w/o antioxidants 
(polyphenols) preparation as adjuvants, to slow the disease progression. However, also the 
surgery approach (trabeculoplasty) is used to reduce the eye pressure [71].  
In this regard, several studies have demonstrated that the polyphenols, whose are product 
of plant metabolism, are capable of defending cells against free-radicals. Indeed, are 
recommended for the several pathological states such as cancer, diabetes, osteoporosis, 
cardiovascular and neurodegenerative disease. As reported by Graft et al (2005) and 
Arts&Hollman (2005), a diet rich in polyphenols is able to counter the inflammatory state 
in order to reduce the risk of chronic disease [72,73]. Another further study showed that 
the eye drops containing Perilla Frutescens with certain flavonoids, catechins and fatty 
acids concentrations, have a protective role on TM from oxidative stress damage [74].  
Moreover, several studies have been focused on RGCs degeneration arrest in glaucoma. 
So, it has been reported the neuroprotective effect of the citidin difosfocolina-5- 
(citicoline) in addition to the hypotensive therapy [75–77]. 
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1.7 Glaucoma model 
1.7.1 In vivo models 
Animal models are widely used in several research field, in particular to study 
multifactorial diseases [78]. Given the evidence that glaucoma is linked with the IOP 
increase, animal induced-models are common used to mimic the effects of IOP elevation 
on RGCs [79]. However, they do not describe the early stage of glaucomatous cascade.  
Many animals have been used including monkeys, dogs, mouse, rats, zebrafish, rabbits, 
sheep, cows, birds, even though, the most representative of human ocular anatomy are non-
human primates (i.e. monkeys), but due to both ethical and economic reasons, their use is 
very limited. In order to mimic the IOP increase, several techniques have been developed 
such as laser photocoagulation of the perilimbal region, autologous fixed red blood cell 
injection or microbeads injection into the anterior chamber, episcleral vein obstruction, 
hypertonic saline injection into the episcleral veins, and so on [80–82]. 
1. Laser photocoagulation of the perilimbal region. Several studies have used laser 
photocoagulation which induced the IOP elevations lead to an increase of resistance of 
outflow pathways, through the angle closure and the SC destruction. Gasterland and 
Kupfer (1974) [83] developed an experimental monkey model that became the standard 
for laser-induced glaucoma. In this experiment they applied circumferential argon laser 
photocoagulation to the TM in each monkey eyes for 4-times. The IOP range was 
between 24 and 50 mmHg and remain elevated for 30 days. This method induce ocular 
inflammation in anterior chamber and irreversible mydriasis. Moreover, the variability 
of IOP magnitude and duration makes this approach not amenable [84,85]. Unlike the 
monkeys, rat and mice model are more easy to maintain in laboratory. Indeed, 
Levkovitch- Verbin (2002) [86] induced experimentally glaucoma in Wistar rats using 
laser photocoagulation to TM or episcleral veins through the external limbus. Laser 
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photocoagulation has led to closure both of intrabecular spaces and the outflow 
conventional pathway. In addition, after 3 weeks of induced elevated IOP , showed 
RGC loss and axonal damage of the optic nerve. But, even in this model, there was 
limitations: the pigmentation of the TM, in rats, lead to a different effects to IOP 
increase and this treatment induced ocular inflammation and corneal opacity. 
2. Microbeads or autologous fixed red blood cell injected into the anterior chamber  
To overcame the disadvantages of laser photocoagulation the microbeads or 
autologous fixed RBC were injected into the anterior chamber of the eye in 
primates, mice, rats, and rabbits [87–89] to induce IOP trough the inhibition of 
aqueous outflow [84]. 
This approach avoids intraocular inflammation but it is not amenable because the 
microbeads are not preserved in anterior chamber angle after injection [90]. 
3. Episcleral Vein Obstruction.  
Shareef et al. (1995) [91] developed a rat model of glaucoma, that includes an 
episcleral vein cauterization which lead to an increase of IOP. This method is less 
invasive than laser photocoagulation and induces no complications in the anterior 
chamber [92]. Because of its efficacy and accessibility, the majority of the 
structural and functional studies in experimental glaucoma have used this method. 
This technique, as reported by Shareef et al. (1995), does not create complications 
in the eye anterior chamber [93]. However, the adverse outcome affect intraocular 
inflammation and ocular surface damage.  
4. Hypertonic saline injection into the episcleral veins.  
Episcleral vein saline injection result an increase in the resistance of acqueous 
outflow channels. Kipfer-Kauer et al. (2010) [94] in C57BL/6 mice have injected 
with 1.5M hypertonic saline into a limbal vein for inducing chronic IOP elevation. 
Unfortunately, the induction technique is relative difficulty and it requires 
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considerable training and experience. Then, the duration of IOP elevation is shortly 
and sequential injections are required to produce IOP changes over time [95]. 
 
Some physiopathological mechanisms of glaucoma have been explained by animal models, 
however, the lack of species specific together with the non-standardized experimental 
conditions make impossible understand all molecular implications to develop new drugs 
and pharmacological interventions [84]. 
1.7.2  In vitro models 
Experimental system in vitro are useful to standardize experimental conditions enabling 
easier manipulation of specific variables, which contribute to degenerative changes of 
glaucoma [96]. In this regard the clinical practice and the research studies on glaucoma, 
have not provided yet a real correlation between the first marks of ocular degenerations 
and the evolution of neurodegenerative implications which lead to irreversible blindness 
[97]. 
Indeed, several in vitro TM model help to clarify the mechanism involved in glaucoma 
disease and to provide new insights into the molecular mechanisms of disease progression 
[57] [82]. 
Therefore, it is important to make species- specific study by using human specific models. 
3D human cultures represent the starter point for reliable in vitro model because they 
preserve the physiological relevance in vivo conditions [98], unlike 2D cultures [99]. 
In a standard procedure, 3D cultures are cultured in a static environment, which in time 
lead to a loss of several cellular functions. Now, it is possible recreate a more complex 3D 
system capable to reflect the in vivo conditions of cells and, also, the injection of chemical 
gradients required (i.e. nutrients and oxygen) by using of a peristaltic pump. In particular, 
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in in vitro model the used of bioreactor technologies, thanks to a “milli-fluidic” system, 
aim to improve the 3D cultures quality by providing, in a constant flow rate, to a 
continuous medium support without exposing cells to a high shear force [100,101]. In 
literature, there are examples of pathological models of heart, lung, intestinal, kidney, 
endocrine, bone-muscle and neurological diseases [101]. These in-vitro models are, in fact, 
more relevant to human physiology because they permit the studying of cell-crosstalk and 
the building of complex in-vitro models as well as allowing further investigation of a tissue 
or an organ and that of their interaction, avoiding the use of animals and following EU 
Commission directives. However, in order to provide an alternative to standard method, 
through the use of dynamic conditions, cells can condition their habitat and interact with 
others, secreting cytokines, and mimicking a real live situation, thanks to the flow of 
medium between the different tissues. This aspect increases cell survival and proliferation, 
allowing, at the same time, the cross-talk between different tissues cultivated in different 
chambers (the so-called inter-organ communication). Moreover, this approach permits the 
study of not only the effect of the drug on the target tissue but also the side-effects on the 
related organs which are in communication due to the medium flow. 
Furthermore, in some in vitro models the elevated of hydrostatic pressure (EHP) have been 
used in several context such as cancer [102,103], hypertension and platelet aggregation 
[104], and cartilage and chondrocyte response [105]. Then, as glaucoma is strongly 
associated with IOP increased, EHP has been used to mimic ocular hypertension on TM 
cells [106,107]. Following the use of bioreactor technologies, the pressure elevation, 
according to the circadian rhythm, was induced by LivePa, a device able to increase by the 
10% the inner pressure inside the culture chamber, thanks to a plunger fitted on it. 
Nevertheless, it is good to keep in mind that in vitro models do not mimic the intricate 
glaucomatous pathology and do not replace the animal models, but could help to clarify the 
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mechanism of this disease and to answer to some important question in a faster and 
cheaper way [81]. 
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Research purpose 
The aim of my research work was focused on three different  tasks. 
1. Comparison of the biological differences of different HTMC cell in vitro models to 
verify which one could best mimic the TM impairment after prolonged oxidative stress 
exposure. In particular, in this task has been subdivided into two steps: 
 Evaluation of different responces in 2D- and 3D-HTMC in vitro models, 
under static culture conditions, after prolonged oxidative stress exposure. 
 Evaluation of different responces in 3D-HTMC in vitro models, under both 
static and dynamic culture conditions, after prolonged oxidative stress 
exposure. 
2. Effects of flow pressure increase on 3D HTMC dynamic model, whereas the increase 
in IOP is one of the main risk factors of glaucoma.  
 
3. Evaluation if the proposed in vitro platform can be considered as an useful tool to 
check the effectiveness of targeted therapies through the modulation of the biomarker 
levels identified. For this purpose, the effects of a concentrated mixture of polyphenols 
(ITRAB®) was analysed in 3D-dynamic HTMC model submitted to prolonged 
oxidative and pressure stimuli.   
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1st Task:  
1.1. Evaluation of different responses in 2D- and 3D-HTMC in 
vitro models, under static culture conditions, after 
prolonged oxidative stress exposure. 
 
MATERIALS AND METHODS  
1.1.1 Cell cultures 
Human trabecular meshwork cells (HTMC) and Trabecular Meshwork Growth Medium 
(TMGM) were from Cell APPLICATION INC. (San Diego, CA, USA). According to 
consensus recommendations reported by Keller et al. [108], Cell APPLICATION 
laboratory gave the official report on the evidence that HTMC cells, made available by 
their Company, express several markers related to a trabecular phenotype, since the HTMC 
resulted responsive to Dexametasone treatment by increased protein level expression of 
fibronectin, α-smooth muscle actin, myocilin and the cross-linked actin networks (CLANs) 
(see: https://www.cellapplications.com/human-trabecular-meshwork-cells-htmc).  
Standard HTMC cultures were performed as monolayers  and grown in TMGM at 37◦C in 
a humidified atmosphere containing 5% CO2, according to the manufacturer’s indications 
and were sub-cultured by TripLE Express (Invitrogen Life Technologies) treatment 
when the original flask was approximately 75% confluent.  
3D cultures were performed by embedding HTMC into Corning Matrigel Matrix 
(Corning Life Sciences, Tewksbury, MA USA). Briefly, a suspension of 500,000 HTMCs 
was slightly centrifuged for 5 min at 90 rcf, and after removing the supernatant, the cell 
pellet was gently resuspended in 200 µl of undiluted Matrigel™ at 4°C. The embedded 
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HTMCs were then gently transferred by pipette into culture chambers (1.9 cm2 growth 
area/dish) and the culture medium was added (1ml/dish) after 15 min, which is the 
necessary time for the Matrigel to reach its gelling state. Then each culture chamber was 
incubated under standard culture conditions. 
2D and 3D-HTMC were seeded at 4 x 10 4/cm2 and 2.5 x 10 5/cm3 cells, respectively, in 
Primo TC Flask 25 cm2, and 96-wells plate (Euroclone, Milano Italy), in BD-
FalconTM cultures Slides (BD Biosciences Europe, Erembodegem, Belgium) and in 
Millipore TC-Plate 24-wells (Merck S.p.a., Merck KGaA, Darmstadt, Germany),  
After seeding both 2D and 3D HTMC cultures were maintained in low and high glucose 
DMEM (1:1 mix) , 2mM L-glutamine, 0.5% gentamicin and 100μg/ml streptomycin, w/o 
Fetal Bovine Serum (FBS) [109], in order to reduce any FBS interference on cellular 
proliferation. 
At the end of the experimental time 2D and 3D HTMCs were harvested by TripLE™ 
Express and from 3D Corning Cell Recovery (Corning Life Sciences B.V., Amsterdam, 
NL), respectively.  
All cell cultures were found to be mycoplasma-free during regular checks with the Reagent 
Set Mycoplasma Euroclone (Euroclone Milan, Italy).  
1.1.2 Experimental condition: Prolonged oxidative stress exposure (72hrs) 
in 2D-HTMC vs. 3D- HTMC static models. 
Prolonged oxidative stress was induced in 2D- and 3D-HTMC up to 72 hrs, by daily 
exposure for 2 hrs to 500µM H2O2, with 22-hour recovery phases in between, according to 
Poehlmann et al., 2013 [110]. The H2O2 concentration was selected on the basis of 
previous experiments to identify a dose that resulted subtoxic, with a MTT viability index 
> 75% versus untreated cultures (data not shown).  
  
28 
 
 
1.1.3 Confocal analysis 
At each selected check point time untreated and treated 2D- and 3D-HTMC, were set in 
4% paraformaldehyde and permeabilized with 0.3% Triton X-100 (Sigma Aldrich®, 
Milan, Italy). Nuclei were stained with To-ProTM -3 Iodide 642/641(Thermofisher 
Scientific Inc., Monza, Italy), actin cytoskeleton was visualized using Phalloidin Alexa 
Fluor 488 (Cell Signaling Technology, Danvers, USA). Fluorescence signals were 
captured at 60X magnification, by Leica TSC SP microscope (Leica Microsystem, 
Wetzlar, Germany) and elaborated by Fiji-ImageJ software, an open-source platform for 
biological-image analysis. Signals from different fluorescent probes were taken in 
sequential scan settings (3D reconstruction images).  
1.1.4 DCF Assay 
The monitoring of ROS production was performed by using the dichlorofluorescein   
(DCF) assay. 2D- and 3D-HTMC cultures were exposed to non-fluorescent 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA, ThermoFisher Scientific Inc.), that 
freely permeates the plasma membrane and is reduced to the highly fluorescent 2',7'-
dichlorofluorescein [111]. Experiments were performed in 96-well plates, and each 
condition analysed 6 times. Cells were seeded in 2D culture medium or in 3D Matrigel as 
already described at 10,000 cells/well the day before. After removing the culture medium, 
HTMCs were briefly rinsed with Hank’s balanced salt solution (HBSS) with calcium and 
magnesium and incubated with 10 M H2DCFDA in HBSS at 37°C in 5% CO2 for 45 
min. Then the H2DCFDA solution was removed and cultures were washed with HBSS and 
challenged with 500µM H2O2 in order to evaluate the ROS production over time in both 
culture models. DCF emission was determined at 2hr, on a fluorescent plate reader, at 
excitation and emission wavelengths of 485 and 520 nm, respectively. The fluorescence 
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intensity was extrapolated after subtracting the blank (medium plus DFC for 2Ds and 
Matrigel plus medium plus DCF for 3Ds) and was expressed as percentage of relative 
fluorescence unit of treated vs untreated HTMC cultures. 
1.1.5 MTT Assay  
At the end of each experimental treatment, the cell viability in terms of mitochondria 
functionality was assessed in 2D and 3D models by MTT assay [112]. The optical densities 
(OD) of the dissolved formazan crystals was determined spectrophotometrically at 570 nm. 
The quantification of cell viability was obtained by comparing the optical density of the 
extracts, and relative cell viability was calculated for each tissue as Arbitral Unit (AU), 
extrapolated by Optical Density (OD) of the samples.  
1.1.6  Alamar Blue Assay 
The 2D- and 3D-HTMC healthy state, in terms of their metabolic activity, was measured 
by Alamar BlueTM (InVitrogen Life Technology) assay daily, during the last 4 hrs before 
the end of the 22 hrs of recovery time, by adding 10% Alamar BlueTM directly in culture 
medium. The assay was carried out according to the manufacturer’s instructions. At each 
check point time, the resazurin reduction was extrapolated spectrophotometrically by 
monitoring absorbance at 570 and 630 nm wavelength. The results were expressed as AU 
extrapolated by OD of each sample. 
1.1.7 Human Apoptosis Array 
Apoptosis was investigated by the semi-quantitative detection of 43 human apoptotic 
proteins, on customized Human Apoptosis Array C1 chip (RayBio; Norcross, GA) (Table 
1). Briefly, after cell lysis each sample was incubated with antibody array membrane ON at 
4°C. The day after, each membrane, after repeated washings with the Wash Buffer I and II 
(provided with the kit), was incubated with biotinylated antibody cocktail for 2 hrs at RT. 
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Then, after washings with abovementioned Wash Buffers, membranes were incubated with 
HRP-Streptovidin for 2 hrs at RT. After further washings, each membrane was incubated 
with detection buffer and the chemioluminescence was detected on radiographic plate. The 
intensity of protein array signals was analysed using a BIORAD Geldoc 2000 and each 
protein spot was normalized against Positive Control Spots printed on each membrane.  
The data analysis was conducted following the Protocol directions of Human Apoptosis 
Array C1. The raw numerical densitometry data were subtracted from background 
(Negative Control signals) and normalized to the Positive Control signals. To determine 
the relative protein expression on different arrays, relating to untreated and treated 
samples, the algorithm according to Human Apoptosis Array C1 protocol was used.  
 
Table 1. The mini map of Human Apoptosis Array C1 (according to RayBio manufacturer manual) 
 
1.1.8 qPCR analysis 
After the cells were treated as mentioned above, the expression profile of selected genes 
was obtained by qPCR analysis. Total RNA was extracted using the RNeasy Micro Kit 
(Qiagen, Milan, Italy) according to the manufacturer's instructions. Quality and quantity of 
RNA was analysed using a NanoDrop spectrophotometer (Nanodrop Technologies, 
Wilmington, DE, USA). The cDNA (150 ng per sample) was synthesized by using 
SuperScriptTM III First Strand Synthesis System (ThermoFisher Scientific, Milan, Italy). 
Each PCR reaction was performed in 10 μl containing: 5× HOT FIREPol EvaGreen 
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qPCR Mix Plus (Solis BioDyne, Tartu, Estonia), 0.2 μM of each primers and 1 ng of 
synthesized cDNA. All samples were analysed in triplicate. The following thermal 
conditions were used: initial denaturation/hot start for 15 min, followed by 45 cycles with 
denaturation at 95° C for 15 s, annealing and elongation at 60° C for 60 s. The fluorescence 
was measured at the end of each elongation step. The next step was a slow heating (1° C/ 
s) of the amplified product from 55° C to 92° C in order to generate a melting temperature 
curve. Values were normalized to ubiquitin (reference gene) mRNA expression. All 
primers (Table 2), were designed using the Beacon Designer 7.0 software (Premier Biosoft 
International, Palo Alto CA, USA) and obtained from TibMolBiol (Genova, Italy). Data 
analyses were obtained using the DNA Engine Opticon 3 Real-Time Detection System 
Software program (3.03 version) and, in order to calculate the relative gene expression 
compared to an untreated (control) calibrator sample, the comparative threshold [113]. was 
used within the Gene Expression Analysis for iCycler iQ Real Time Detection System 
software (Bio-Rad) [114] . Data are means ± S.D. of at least three independent experiments 
performed in triplicate. 
GENE GenBank  Forward  Reverse Size (bp) 
IL-1alpha NM_000575.4 CAATCTGTGTCTCTGAGTATC TCAACCGTCTCTTCTTCA 112 
IL-1beta NM_000576.2 TGATGGCTTATTACAGTGGCAATG GTAGTGGTGGTCGGAGATTCG 140 
IL-6 NM_001318095.1 CAGATTTGAGAGTAGTGAGGAAC CGCAGAATGAGATGAGTTGTC 195 
Ubiquitin C NM_021009.7 ATTTGGGTCGCAGTTCTTG TGCCTTGACATTCTCGATGGT 50 
Table 2. Primer sequences used for real time quantitative polymerase chain reaction analysis. 
1.1.9 Western Blot Analysis 
Cell lysates were collected using RIPA buffer (Sigma Aldrich) plus protease inhibitor 
cocktail (Complete Tablets, Roche Diagnostic GmbH, Mannheim Germany) and sonicated 
until solubilized. 25mg of proteins were resolved in Ani kDTM mini precast gel (Bio-Rad 
Laboratories, Inc., Hercules, CA, USA) in SDS-PAGE Running Buffer and transferred 
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onto PVDF membrane (Thermo Scientific, Rockford, USA) and probed with primary 
antibodies against rabbit, phospho-NF-kB p65, Ser 536 (Cell Signaling Technology,) and 
mouse GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA ) followed by 
incubation with HRP-conjugated secondary antibodies (NA9340V and NA931V, against 
rabbit and mouse primary antibodies, respectively, Amersham Life Science, Milano, Italy). 
The proteins were detected by Western BrightTM ECL (Advansta, CA, USA), exposed to 
film and analysed using a BIORAD Geldoc 2000. The data presented were calculated after 
normalization with GAPDH. Densitometrical data obtained from Quantity One software 
(Bio-Rad) were applied for statistical analysis and normalized against the housekeeping 
GAPDH. The results were expressed as fold vs untreated cultures, respectively. 
1.1.10  Statistical Analysis. 
Reported data are expressed as mean ± Standard Deviation (SD) and results were analyzed 
using two-way analysis of ANOVA for single comparison or two-way analysis of ANOVA 
variance followed by Bonferroni posttest for multiple comparisons. GraphPad Prism for 
Windows- version 5.03 and GraphPad Software, Inc., La Jolla, CA, USA) was used. 
Statistically significant differences were set at p<0.001; p<0.01; p<0.05. 
Results 
Confocal analysis  
Spatial organization of 2D- and 3D-HTMC cultures was analysed by confocal microscopy 
at the end of the experimental conditions, by cell imaging reconstruction. The merged 
images of untreated and H2O2-treated HTMC cultures did not show any visible changes 
both in F-actin and in the nuclei structures. However, from a qualitative point of view, 2D-
HTMCs showed a reduction of cell-to-cell interaction compared to the 3D model, in which 
cells showed an oblong morphology and better-ordered distribution in the matrix with a 
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Fig.1: Confocal analysis. Confocal microscopy analyses of nucleus and cytoskeletal markers were performed on 
untreated and H2O2-treated 2D- 
related to immunoreactivity for To
images showed cytoskeleton plus Nucleus. Fluorescence signals were captured at 60x magnification
 
DCF assay  
The fluorometric DCF assay was performed in order to evaluate the ability of hydrogen 
peroxide to induce ROS production in the 2D
hydrogen peroxide was investigated, either keeping it or not keeping it in HTMC culture 
medium, beyond the two hours. In both HTMC models the ROS production was therefore 
quantified at 2 hrs (Figure 2
over time was already observed after 
3D increased their intracellular ROS production by about 
cultures.  
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Fig.2: DCF assay. DCF assay were performed on untreated and H2O2-treated 2D- and 3D HTMC cells after 2 hrs of 
experimental procedures. Data are expressed as % of untreated HTMC and represent the mean ± SD of 3 independent 
experiments. ***p <0.001 vs respective untreated cultures and #p<0.001 vs 500µM H2O2 treated HTMC (Two-way 
ANOVA followed by Bonferroni’s test). 
 
Mitochondrial respiratory functionality 
MTT assay was carried out as a ‘gold standard’ to evaluate cell viability by reference to the 
mitochondrial compartment functionality during chronic stress exposure (Figure. 3, a). 
After 24 hrs of experimental treatment, the viability index of H2O2-treated HTMC revealed 
an impairment in both culture models, although it was slightly more marked in 3D- than in 
2D-cultures. However, during the following experimental time of exposure to oxidative 
stress, the mitochondrial functionality resulted restored in both 2D- and 3D-HTMC 
models, probably indicating an adptive response to H2O2.  
 
Alamar Blue Assay 
The effects of chronic 500µM H2O2 exposure on 2D-and 3D-HTMC were measured at 
each check point time up to 72 hrs, by Alamar Blue assay (Figure. 3, b). 2D HTMC 
exposed to chronic stress reflected the general trend of untreated cultures, with a decrease 
of resorufin reduction at the end of the experimental treatment. Conversely, untreated 3D 
HTMC cultures showed a constant increase of metabolic activities and even during 500µM 
  
H2O2 chronic treatment
significant increase of their metabolic state as opp
decreased slightly after 72 
untreated cells.  
 
Figure 3. Effects of chronic H
functionality. MTT assay was performed in 2D
Metabolic state of untreated and H
by Alamar blue assay. Data are expressed as A.U. of MTT test and of resazurin reduction of each HTMC cu
represent the mean ± S.D of 3 separated experiments, in triplicate. 
*p <0.05 treated vs respective untreated cultures
@@p<0.01 untreated 72 hrs vs untreated HTMCs 4
aaap<0.001 aap<0.01; ap<0.05, treated 72 hrs vs treated HTMCs 48 hrs. (Two
posttest). 
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Apoptosis Array 
Pro- and Anti- apoptotic protein levels were analysed by Human Antibody Array C1 
(RayBio C-Series) using 43 different antibodies (Figure. 4). The array patterns 
highlighted the differences between the 2D- and 3D-HTMC model, in apoptosis ignition. 
In particular, 3D-HTMCs showed a high throughput profiling in response to the hydrogen 
peroxide, compared to 2D.  
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Figure 4. Apoptosis Array. Analysis of anti- apoptotic and pro- apoptotic protein levels in 2D- and 3D-HTMC were 
performed after 48 (panel A) and 72h panel B) of 500µM H2O2, by Human Antibody Array C1 (RayBio C-series).The 
light blue dotted line represents the protein level of untreated HTMC for each of the 43 proteins examined. For each time 
point twelve individual models were arrayed (six 2D-HTMC plus six 3D-HTMC) and per experiment the intensity of 
Positive Control Spot was used to normalize signal responses for comparison of results across multiple arrays. 
***p<0.001;**p<0.01; *p<0.05; vs. respective untreated cultures (One-way ANOVA followed by Bonferroni posttest). 
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qPCR analysis 
The trigger of a pro inflammatory response in 2D- and 3D-HTMCs after 48 and 72 hrs 
exposure to OS, was analysed in terms of gene expression levels of IL-1, IL-1α and IL6 
by qPCR (Figure. 5, A). At 48 hrs, untreated 2D HTMCs showed a lower levels of basal 
gene expression of all cytokines compared to HTMCs cultured in 3D conditions according 
to Regier et al., [115]. Moreover, at this time point, only treated 3D-HTMCs revealed a 
slight, but significant increase of IL1 level. 
Conversely, at 72 hrs treated 2D-HTMCs showed a marked increase of IL1 of about 15 
fold compared to untreated 2D-cultures, while in 3D-HTMCs an increase of IL1, IL1β 
and IL6 of about 3, 2 and 1.5 fold respectively, was observed compared to the untreated 
3D-HTMCs.  
Western Blot Analysis 
The level of NF-kB transactivation was detected by a specific kit containing antibodies 
against both NF-kB p65 and the phospho-NF-kB p65 subunit to check the inflammatory / 
antiapoptotic response activation. 
2D- and 3D-HTMCs were treated for 24-48-72 hrs as mentioned above and the NF-kB 
activation was analysed in terms of the ratio between the levels of phospho-NF-kB p65/ 
NF-kB p65 (Figure 4B). Phospho-NF-kB p65 protein content was up-regulated by H2O2 
treatment (Figure. 5E) only in 3D-HTMCs (p<0.001) when compared to both the 
untreated culture models and the treated 2D-models.  
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Figure 5. Induction of pro inflammatory factors by chronic H2O2 treatment. Quantitative PCR gene expression 
analysis of 2D- and 3D-HTMCs subjected to 500μM H2O2 for 48 h and 72 h. IL-1α(A), IL-1 (B), and IL-6 (C) gene 
levels. Data are expressed as fold-increase relative to the 2D and 3D control cultures at the same end-point and 
normalized to Ubiquitin housekeeping gene expression. Each bar represents the mean±S.D. of three independent 
experiments performed in triplicate. (D) Representative immunoblot showing NF-kB (p65) and  p-NF-kB (p65) protein 
levels of untreated (U.T.) and treated HTMC (H2O2) whole protein lysates at indicated time points. GAPDH was used as 
an internal control for equal protein loading on the gel. (E) NF-kBp65 activation was evaluated in HTMC cells subjected 
to chronic treatment with H2O2 for 24, 48 and 72 hrs. The analysis was performed by immunoblotting and the bars 
represent the ratio of phosfoNF-kBp65/NF-kBp65, and are expressed as fold vs. untreated HTMC cultures. Data 
represent the mean ± S.D. of 3 independent experiments.  
***p <0.001, * p <0.05 treated 3D-HTMCs vs. untreated 3D-HTMCs cells; ### p<0.001, # p <0.05 untreated 3D-HTMC 
vs. untreated 2D-HTMC cells; §§§p<0.001 treated 3D-HTMC vs. treated 2D-HTMC cells (Two-way ANOVA followed 
by Bonferroni posttests). 
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Conclusions 
Nowadays, cell cultures are used in biomedical research, tissue engineering, regenerative 
medicine and industrial practices. Two-dimensional 2D cell cultures are the most popular, 
but is increasingly gaining ground the three-dimensional (3D) cultures with a more realistic 
biochemical and biomechanical microenvironments [116].  
As known, in in vivo microenvironment all cells are surrounded by ECM and by other 
cells, however the 2D cell cultures due to the support accession, do not mimic the natural 
environment of cells [117] [118]. This was demonstrated by confocal analysis which 
highlighted that only HTMC embedded in Matrigel allowed the development of the 
complex architecture in terms of dimension and cell-to-cell contact. Indeed, the 2D HTMC 
showed a more confused pattern with less definition of both F-actin and nuclear shape due 
to the cells flattening typical of a bi-dimensional culture condition (Figure 1).  
Moreover, the cellular ROS production after 2hrs of H2O2 exposure was evaluated by DCF 
assay in order to demonstrate that the matrix used for 3D cultures did not interfere with 
HTMCs biological response. In our previous work [119], we analysed the cellular ROS 
production after H2O2 over time and it has already been demonstrated that 2 hr exposure 
time was sufficient to promote the intracellular ROS production without difference in 
terms of cytotoxicity exerted by H2O2. 
Therefore, the 3D model shown a higher sensitivity to OS compared to standard 2D 
cultures because their spatial architecture maintained a more physiological setup (Figure 
2).  
Regarding the maintainance of cell health state, we observed that the flattening of 2D cell 
culture influences many cellular processes including cell proliferation, apoptosis, gene and 
protein expression, while the 3D culture thanks to the interactions between cell to cell and 
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cell to ECM preserves the cell functions found in vivo [117]. Moreover, it had been 
demonstrated also by previous studies that the ECM around cells in 3D models, can 
significantly impact cell proliferation, differentiation, mechano-responses, and cell survival 
[120]. 
Indeed both MTT and Alamar blue assay (Figure 3a, 3b), showed a time-dependent 
reduction of viability index only in 2D-HMTCs while, in 3D-HMTCs a slightly reduction 
was observed only after the early 24 hrs, instead in the following period of pulsed stress, an 
adaptation phenomenon with a homeostasis restoration was observed.  
The apoptosis array revealed that 3D HTMCs were more able to counteract the pro-
apoptotic proteins activation in response to daily H2O2 exposure, than the 2D model 
(Figure 4a, 4b). In fact, the significant increase of anti-apoptotic proteins such as Survivin, 
the pro-survival member of the Bcl-2 family, IGF1 and IGF2, was likely to sustain cell 
viability through apoptosis inhibition as already reported [121–125], despite the increase of 
caspase 3, BID and BAD. Moreover, the increase of TNFR1 levels suggested to us that 
also the pro-survival NF-kB transcription factor could be involved in this resistance to 
apoptosis [126].  
In this regard, we also analysed the pro-inflammatory profile by cytokines gene expression 
and the NF-kB activation. Thus, after the first couple of H2O2 pulses the parallel activation 
of phosfo-NF-kB p65 and the expression of the inflammatory genes it controlled were not 
yet detectable, in both of models (Figure 5 panel A,B,C,D, E) probably due to a 
temporary NF-kB activation with no memory of the previous challenges and no signal 
accumulation visible by WB [127]. 
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Conversely, in the 3D model after 72 hrs exposure the phospho-NF-kB subunits showed a 
marked and significant increase (p<0.001), compared to the control untreated cells and also 
to the 2D.  
These effects suggested that in 2D model the HTMCs did not retain memory of the 
previous OS pulses even at 72 hrs while in the 3D model the NF-kB activation memory at 
last has been established leading to the onset of a chronic inflammatory response like in 
vivo condition [99]. Moreover, only in the 3D HTMC model a significant increase of IL1α 
(p<0.05) gene transcription was observed compared to the untreated 3D-HTMCs 
confirming the hypothesis of a mild temporany activation of the inflammatory pathway 
[127] after the first two pulses. However, at 72 hrs, all cytokines tested in the 3D model 
(IL1α, IL1β, IL-6) were significantly up-regulated with the corresponding NF-kB 
sustained activation at this time point.  
These findings suggested that 3D-HTMC model, compared to 2D HTMC model, 
resembles physiologically TM features in vivo [99]. The TM-matrix embedded cells seem 
more sensitive to the OS reflecting in a more realistic way the OS role in TM degeneration 
which leads to the neuroinflammatory and glaucoma neurodegenerative outcomes.  
  
  
1.2. Evaluation of different respon
models, under both static and d
prolonged oxidative stress exposure
 MATERIALS AND METHODS 
1.2.1. Cell cultures
See paragraph 1.1.1 
1.2.2. Dynamic 3D HTMC model
3D-HTMC were performed in LiveBox1, a transparent chamber provided by IVTech srl. 
Twenty-four hours after 
by connecting each perfusion chamber to a peristaltic pump able to maintain a constant 
growth medium flow rate of 
allow the cell-to-cell interactions
diffusional limitations and soft gel degradatio
Fig.6: Perfusion bioreactor circuit diagram
peristaltic pump, through the perfusion chamber where 3D
completing the circuit. The image represents only one circuit, but the flow system includes two head pumps connected 
whit at least four perfusion chamber
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ses in 3D-HTMC in vitro 
ynamic culture conditions, after 
 
 
  
 
seeding, 3D-HTMC culture were submitted to a millifluidic circuit 
70µL/min (LiveFlow, IVTech srl) for four days in order to 
 [128]. The flow rate has been set to overcome both 
n on 3D-HTMC (Figure
. The medium from medium reservoir is pumped by the action of the 
-HTMCs were seeded, then it returns to the medium reservoir, 
s. (Kind permission of IvTech, Srl) 
.6). 
 
  
44 
 
1.2.3. Experimental condition: prolonged oxidative stress exposure (168hrs) 
in 3D HTMC model under static and dynamic culture conditions. 
Prolonged oxidative stress effect in both 3D-models lasted for a week (168 hrs) exposing 
once a day for 2 hours 3D-HTMCs to 500µM H2O2, followed by 22h of recovery, 
according to Poehlmann et al., 2013 and Kaczara et al., 2010 [110,129]. All molecular 
analyses on static and dynamic 3D-HTMC cultures were conducted once cells were freed 
from Corning Matrigel Matrix (Corning Life Sciences, Tewksbury, MA USA) by 
Corning Cell Recovery (Corning Life Sciences), according to the manufacturer’s 
instructions. 
1.2.4. Alamar Blue Assay 
See paragraph 1.1.6 
1.2.5. qPCR analysis 
See paragraph 1.1.8  
Primers used are shown in the Table 3. 
GENE GenBank  Forward  Reverse Size (bp) 
IL-1 NM_000575.4 CAATCTGTGTCTCTGAGTATC TCAACCGTCTCTTCTTCA 112 
IL-1 NM_000576.2 
TGATGGCTTATTACAGTGGCAAT
G 
GTAGTGGTGGTCGGAGATTC
G 140 
IL-6 NM_001318095.1 CAGATTTGAGAGTAGTGAGGAAC 
CGCAGAATGAGATGAGTTGT
C 195 
MMP-1 NM_001145938.1 GGTGATGAAGCAGCCCAGATG 
CAGAGGTGTGACATTACTCC
AGG 187 
MMP-3 NM_002422.5 TAATAATTCTTCACCTAAGTCTCT AGATTCACGCTCAAGTTC 99 
MMP-9 NM_004994.2 AACCAATCTCACCGACAGG CGACTCTCCACGCATCTC 85 
TNF NM_000594.4 GTGAGGAGGACGAACATC GAGCCAGAAGAGGTTGAG 95 
TGF-2 NM_001135599.3 AACCTCTAACCATTCTCTACTACA 
CGTCGTCATCATCATTATCAT
CA 149 
Ubiquitin C NM_021009.7 
ATTTGGGTCGCAGTTCTTG TGCCTTGACATTCTCGATGGT 50 
Table 3. Primer sequences used for real time quantitative polymerase chain reaction analysis. 
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1.2.6. Human Apoptosis Array 
See paragraph 1.1.7 
1.2.7. Western Blot Analysis 
See paragraph 1.1.9 
1.2.8. Confocal Analysis 
See paragraph 1.1.3. 
1.2.9. Statistical Analysis.  
Reported data are expressed as mean ± Standard Deviation (SD) and results were analyzed 
using two-way analysis of ANOVA for single comparison or two-way analysis of ANOVA 
variance followed by Bonferroni posttest for multiple comparisons. GraphPad Prism for 
Windows- version 5.03 and GraphPad Software, Inc., La Jolla, CA, USA) was used. 
Statistically significant differences were set at p<0.001; p<0.01; p<0.05. 
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Results 
Alamar blue Assay  
The effects of chronic 500μM H2O2 exposure were daily measured on 3D-HTMCs culture 
in static and dynamic conditions at each check point time up to 168 hrs, by Alamar Blue 
assay (Figure. 7).  
After 24hrs of oxidative stress conditions, in 3D-static HTMC cultures the metabolic state 
showed a significant increase compared to untreated cultures (about 50%), and the reached 
levels in the following time exposure resulted in a time dependent decrease. After 24-48 
hrs of prolonged oxidative stress, 3D-static HTMCs exhibited about 50 % increase of 
metabolic activity compared to the respective untreated cultures and 80% versus 3D-
dynamic HTMCs. These effects decreased slowly during the following time exposures, and 
at 96 hrs the metabolic rate resulted similar to that of control cultures, and after 120 hrs of 
prolonged stress conditions, HTMCs exhibited a further impairment of metabolic state 
reaching lower values than those of untreated cultures. Instead, the metabolic trend of 3D- 
dynamic HTMCs did not evidence significant modulation within 24 hrs of applied stress. 
Nevertheless, over days, repeated OS exposure produced a significant drop of viability 
index (about 20% vs untreated dynamic cultures) that while remaining lower until 96 hrs, 
took to a slow recovery and starting from 144 hrs 3D-dynamic HTMCs showed a 
metabolic rate index similar to control cultures. 
  
  
Fig. 7. HTMC metabolic state.
dynamic conditions was analyzed by Alamar blue assay, during the last 4 hrs of the 22 hrs recovery time in between daily 
exposure to oxidative stressor.  
represents the mean ± SD of 3 separate experiments running in triplicate. **p<0.01; ***p <0.001 vs untreated 3D
HTMCs (Two-way ANOVA). 
 
q-PCR  
In order to evaluate the pro inflammatory cytokines 
after OS treatment on 3D
treated as mentioned above. The gene expression levels of IL
TGFβ, MMP1, MMP3 and MMP9 were analyzed by qPCR 
treated 3D-dynamic HTMCs showed an up
MMP9, compared to untreated cultures, however 3D
significant increase of markers investigated.
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 Metabolic state of untreated (UT) and H2O2 treated 3D HTMCs cultured in static and 
Data are expressed as “fold” Vs viability index of untreated 3D
modulation and
-HTMCs cultured in a static and dynamic manner, the cells were 
-1α, IL
(Figure. 
-regulation of IL1β, TGFβ, MMP1, MMP3 and 
-static HTMCs did not evidenced a 
  
 
 
-HTMC, and each value 
-
 the MMPs regulation 
-1, IL6, TNFα, 
8). At 48h only OS-
  
 
Fig. 8: qPCR. Quantitative PCR
subjected 500μM for 48h. IL-1α, IL
fold-increase relative to control at the same end
bar represents the mean ± SD. of three independent experiments performed in triplicate.
3D-HTMCs (Two-way ANOVA).
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 gene expression analysis of 3D-HTMCs cultured in static and dynamic conditions and 
-1, IL6, TNFα and TGFβ (A), MMP1, MMP3 and MMP9 (B). Data are expressed as 
-point and normalized to Ubiquitin housekeeping gene expression. Each 
 **p <0.01
 
 
 
;*p<0.05; vs untreated 
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Human Apoptosis Array  
After prolonged OS stress, multiple marker detection of apoptosis pathway was analyzed 
on both 3D-HTMC models by a microarray for 43 pro/anti apoptotic proteins. In Figure. 8 
we reported only the levels of those pro/anti-apoptotic proteins that resulted in significant 
modulation in almost one or in both 3D-HTMC models. 
After 48 hrs OS exposure, 3D-static HTMCs evidenced a significant increase of pro-
apoptotic BID, BIM, Caspase 3, p53, Smac, TNF-R1 proteins (Figure. 8, A). This 
modulation resulted more marked after 72 hrs for above proteins, except for proapoptotic 
p53 and Smac. Regarding antiapoptotic molecules, the OS exposure after 48hrs resulted in 
a significant increase Survivin, IGFBP1 and IGF1, and after 72 hrs, a stronger increase of 
BCL2, BCLw, survivin, x IAP, CD 40 and IGF1. These modulations of pro and anti-
apoptotic markers are lapsed in 3D-static cultures at 168 hrs, 
In dynamic conditions, after 48 hrs of OS stimulus, pro-apoptotic BAD, BID, BAX, BIM, 
CytoC, Smac and TNFα, TNFα/TNFR1, TNFα/TNFR2 protein levels were significantly 
increased compared those of control cultures. At 72 hrs the levels of almost all markers 
were at basal levels, except for TNFα, TNFα/TNFR1, TNFα/TNFR2 which rose in a time 
dependent way until 168 hrs. As for anti-apoptotic patterns, only IGFBP1 evidenced a 
significant increase after 48 hrs, while BCL2, BCLw, Hsp70, CD40, IGFBP1 and IGF1 
showed up to 3 fold increase after 168 hrs. 
  
 
 
A
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Fig. 8: Apoptosis array. Analysis of pro
HTMCs cultured in static and dynamic conditions, were performed after 48
Antibody Array C1 (RayBio C
reported. The light blue dotted line represents the protein level of untreated HTMC for each protein examined. Twelve 
individual models were arrayed (six static 3D
Positive Control Spot was used to normali
** p<0.01; ***p<0.001 vs. respective untreated cultures (One
 
B
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- and anti- apoptotic protein levels (Panel A and Panel B, re
-72-168hrs of 500μM H
-series). In the graphs only the analysis of the markers significantly modulated were 
-HTMCs plus six dynamic 3D-HTMC) and per experiment the intensity of 
ze signal responses for comparison of results across multiple arrays
-way ANOVA). 
 
 
spectively) in 3D-
2O2, by Human 
. *p<0.05; 
  
Western Blot Analysis
The analysis of PARP-
hours of exposure to chronic pro
exposure to H2O2 exerted opposite effects on 3D
conditions, in fact, a marked and significant increase of PARP
detected only in 3D-HTMCs static cultures, while in dynamic models 3D
expression got a full length. NF
response marker, was analyzed in terms of the ratio between the levels of phospho
p65, the activated form of NF
activation occurred only in 3D
Fig. 9: PARP1 cleaved levels and NF
oxidative treatment. The analysis was performed by immunoblotting and the bars represent the both ratio of cleaved 
PARP1 and phosfoNF-kBp65/NF
independent experiments, running in triplicate. *** p <0.0001; **p<0.01 vs. untreated 3D cultures and §p<0.0001 3D
HTMC treated vs 3D-HTMC control cultures (Two
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1 full length-cleavage was performed on 3D
-oxidant stimulus (500μM H2O2) (Figure. 
-HTMCs depending on the culture 
-1 cleavage levels was 
-kB transactivation, as an inflammatory / antiapoptotic 
-kB, versus total NF-kB (Figure 9, B). A remarkable NF
-HTMC cultured in dynamic conditions.
-kB levels in 3D- HTMC static and dynamic cultures after 168hrs 
-kB, and are expressed as arbitrary units (AU). Data represent the mean ± SD of 2 
-way ANOVA).  
 
-HTMCs, after 168 
9, A). Chronic 
-HTMCs PARP-1 
-NF-kB 
-kB 
  
 
of chronic 
-
  
Confocal analysis  
After 168 hrs of experimental procedures, spatial organization of 3D
analyzed by confocal microscopy (
In the 3D- static HTMC cell imaging reconstruction
microfilaments, detected by fluorescent probe FITC
distributed in parallel lines along wi
interaction was detected. However, in dynamic 3D
microfilaments showed less orderly distribution of the cells embedded in the matrix. In 
both culture conditions, the H
labeled by fluorescent probe To
and distributed in radial manner only in dynamic conditions.
Fig. 10: Confocal analysis. Confocal microscopy
untreated and H2O2-treated 3D-HTMCs in static (on the left) and in dynamic (on the right) conditions after 168 hours of 
experimental procedures. Representative images are related to immunoreac
and cytoskeleton markers, respectively. Merged images showed cytoskeleton plus Nucleus. Fluorescence signals were 
captured at 60x magnification.  
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Figure. 10). 
 it can be observed that 
-Phallodin, resulted uniformly 
th the longitudinal axis and a lot of cell
-HTMCs imaging reconstruction
2O2- treated 3D-HTMCs showed an increase of nuclear size, 
-ProTM, while actin microfilament became thickened, tense 
  
 analyses of nucleus and cytoskeletal markers were performed on 
tivity for To-Pro
-HTMCs cultures was 
the actin 
-to-cell 
, actin 
 
TM and Phalloidin, as nuclear 
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Conclusions 
As reported in the above study, we have been demonstrated the reliability of the 3D culture 
model to assess a realistic HTMC model. However, to further increase the 3D-HTMC 
complexity, we approached to the millifluidic technique. Indeed, in the last few years 3D-
cultures together with 3D-culture techniques have represented important steps towards in 
vitro models ever more physiologically relevant and useful for disease species-specific 
studies. In particular, the addition of a perfusion flow ranging from milli- to micro-fluidic 
techniques have implemented the performance of standard 3D-cultures. Duval et al. (2017) 
reported that cells and tissues cultured in vitro, under specific conditions, maintain power 
law metabolic scaling in cultures proving the physiological relevance for these downscaled 
in vitro systems [116].  
Taking in account these results, we analyzed the 3D-static and dynamic HTMC culture 
morphology by confocal microscopy at the end of chronic OS exposure (Figure.10). The 
F-actin was chosen as cytoskeleton indicator because resulted abundant in TM cells. In our 
experimental conditions, after 168 hrs exposure to oxidative stressor, in dynamic 3D-
HTMCs cultures actin microfilaments appeared thinned and nuclear size resulted in an 
enlargement compared to that of untreated cultures.  
Considering these observations together, it can be argued that chronic OS induced an F-
actin cytoskeleton reorganization and altered the cell adhesive properties of 3D-HTMCs. 
As occurs during glaucoma, the TM cells undergo diffuse injury, with increased oxidative 
stress leading to both an alteration of motility of the entire TM and an alteration of the 
barrier; this scenario subsequently leads to an increase in IOP [130]. 
The molecular damage related to OS in both 3D-HTMC models was investigated through 
the amplification of five cytokines including IL1, IL1β, IL6, TNF and TGFβ, by qPCR.  
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After 48hrs of experimental stress conditions, we found a significant up-regulation of 
TGF-β1 and IL-1β, two crucial markers involved in ECM remodeling by regulating the 
autophagic signal pathway [131,132] and acute inflammatory response in several diseases 
including glaucoma eyes [133], only in dynamic 3D-HTMC cultures. Therefore, the 
increase of these two cytokines by the OS is relevant because the impairment of the 
trabecular reticulum motility is one of the first molecular events of glaucoma occurrence 
(Figure. 8A). 
Moreover, we also evaluated the MMPs gene amplification because, as known, their 
enhanced activation could play a central role both in the remodeling of ECM during the 
ocular growth and development and in remodeling TM ECM to counteract the outflow 
resistance and IOP in glaucoma [134,135]. In this regard, I investigated the gene 
expression of MMP1 and MMP3 in both culture models but only in 3D-dynamic cultures 
they were up regulated by the pro oxidant stimulus, underlining how more physiological 
culture conditions are able to better mimic the homeostatic TM cell responses found in 
vivo to adjust the outflow resistance [136,137]. 
Furthermore, 3D-HTMC models, compared to the standard 2D cultures commonly used for 
in vitro glaucoma studies, showed to maintain the tissue architecture polarity which 
represents an important hallmark for the tissue function maintenance found in vivo. 
However, a dynamic environment allows a better maintenance of cell structures than static 
culture conditions, also confirmed by confocal analysis, and this capability better 
supported the cellular polarization, sustaining, as a consequence, a long-term viability of 
the cells. Indeed, the modulation of apoptosis markers and NF-kB protein levels in 3D- 
dynamic HTMC cultures showed a more efficient adaptive response over time to OS-
damage, compared to 3D-static models [138], triggered the inflammation cascade, as it 
happens in vivo during glaucoma occurrence. 
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Then, in 3D-dynamic HTMCs we observed an increase of pro apoptotic proteins including 
BAD, BIM, BID, and cytochrome C only in early time of pro-oxidant stimulus exposure 
and a gradually increase over time of TNFα and its receptor 1 (TNFR1). However, a 
stronger increase at 168hrs of anti-apoptotic markers, as survivin and IGFPB1 and in a way 
also TNFR2 (TNF receptor 2), that acts as cell proliferation activator, was found to 
counterbalance the apoptotic response (Figure. 8B). Moreover, these results together with 
the uncleaved PARP1, the increase of phosfoNF-kBp65 rate compared to total NF-kB level 
and the healthy metabolic state were in favour of cell survival rather than apoptosis. 
On the other hand, 3D- static HTMC cultures evidenced an overexpression of BAD, BID 
and Caspase 3 and to a lesser extent also of TNRF1 and also a marked induction of anti-
apoptotic proteins such as BCL2, BCLw, survivin, x IAP, CD 40 and IGF1 up to 72hrs of 
OS-exposure. Nevertheless after 168hrs to prolonged sub-toxic stress exposure we reported 
PARP1 cleaved, no activation of NF-kB and a reduced metabolic cell state leading to 
hypothesize that 3D-static HTMCs carried on to apoptosis pathway (Figure 9) [139,140]. 
As reported by Duval et al. (2017), cells and tissues cultured in vitro, under specific 
conditions, maintain power law metabolic scaling in cultures proving the physiological 
relevance for these downscaled in vitro systems [141]. Moreover, the cross-talk between 
cells allows to condition their habitat so as to interact with each other (i.e. cytokines 
secretion) by promoting cell survival and proliferation, in a more realistic manner even 
after stimuli, such as oxidative stress. In conclusion, in our study the 3D-in vitro model 
exploiting a millifluidic technology turns out to be a useful tool providing a physiological 
cellular environment under controlled experimental conditions. 
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2nd task: Effects of flow pressure increase on 3D HTMC 
dynamic model, whereas the increase in IOP is one of the main 
risk factors of glaucoma. 
 
MATERIALS AND METHODS  
2.1. Cell Cultures 
See paragraph 1.2.1 
 
2.2. Experimental conditions: applying of flow pressure increase in dynamic 
3D - HTMC models. 
In order to mimic the IOP-increase Live Pa (IVTech srl), an auxillary device, was 
connected to bioreactor system up to 168hrs (Figure.11) . Live Pa increases by 10% the 
culture chamber pressure thanks to a plunger which compress the output pipe of LiveBox1. 
Indeed, following the allometric calculation scale [128,141], the value of pathological 
pressure derived from the basal pressure of the bioreactor was 100µl/min=0.02KPa. So, the 
pathological pressure was 100µl/min= 0,022 kPa. 
By this way, 3D-HTMCs were mainatained for 24 hrs/day under dynamic conditions and 
for 12hrs/day were submitted to an increase of flow pressure, following the circadian 
rhythm. All molecular analyses on dynamic 3D-HTMC cultures were conducted once cells 
were freed from Corning Matrigel Matrix (Corning Life Sciences, Tewksbury, MA 
USA) by Corning Cell Recovery (Corning Life Sciences), according to the manufacturer’s 
instructions 
  
  
 
Fig.11: Perfusion bioreactor circuit diagram
action of the peristaltic pump, through the perfusion cha
indicated by the arrow, press the output pipe of Live Box1, increasing the pressure inside the chamber.
of IvTech srl)  
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 plus Live Pa. The medium from medium reservoir is pumped by the 
mber where 3D-HTMCs were seeded. The plunger of Live PA, 
 
 (Kind permission 
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2.3. Alamar Blue Assay 
See paragraph 1.2.4 
2.4 Confocal Analysis 
See paragraph 1.2.8 
2.5 qPCR analysis 
See paragraph 1.2.5. Primers used are shown in the Table 4. 
GENE GenBank  Forward  Reverse Size (bp) 
Alpha-
SMA 
NM_001141945.
1 TTGAGAAGAGTTACGAGTTG 
GGACATTGTTAGCATAGAG
G 189 
Collagen 
1A NM_000088.3 
CTTTGCATTCATCTCTCAAACTT
AGTTTT CCCCGCATGGGTCTTCA 163 
Myocilin NM_000261.2 GTTACCACAAGCCACAAT GAAGCATTAGAAGCCAACT 112 
MMP-1 NM_001145938.1 GGTGATGAAGCAGCCCAGATG 
CAGAGGTGTGACATTACTCC
AGG 187 
MMP-3 NM_002422.5 TAATAATTCTTCACCTAAGTCTCT AGATTCACGCTCAAGTTC 99 
MMP-9 NM_004994.2 AACCAATCTCACCGACAGG CGACTCTCCACGCATCTC 85 
SPARC NM_003118.4 ATGGTTCCTGTAAGCACTAA TGAATGAATGAATGAATGAATGC 143 
TGF-
beta2 
NM_001135599.
3 
AACCTCTAACCATTCTCTACTA
CA 
CGTCGTCATCATCATTATCA
TCA 149 
IL-1alpha NM_000575.4 CAATCTGTGTCTCTGAGTATC TCAACCGTCTCTTCTTCA 112 
IL-1beta NM_000576.2 TGATGGCTTATTACAGTGGCAATG 
GTAGTGGTGGTCGGAGATTC
G 140 
IL-6 NM_001318095.1 
CAGATTTGAGAGTAGTGAGGA
AC 
CGCAGAATGAGATGAGTTG
TC 195 
Ubiquitin 
C NM_021009.7 
ATTTGGGTCGCAGTTCTTG 
TGCCTTGACATTCTCGATGG
T 50 
Table 4. Primer sequences used for real time quantitative polymerase chain reaction analysis. 
2.6 Western Blot Analysis 
See paragraph 1.2.7 
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2.7  Statistical Analysis 
Reported data are expressed as mean ± Standard Deviation (SD) and results were analyzed 
using two-way analysis of ANOVA for single comparison or two-way analysis of ANOVA 
variance followed by Bonferroni posttest for multiple comparisons. GraphPad Prism for 
Windows- version 5.03 and GraphPad Software, Inc., La Jolla, CA, USA) was used. 
Statistically significant differences were set at p<0.001; p<0.01; p<0.05. 
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 Results 
Alamar blue Assay 
The effects of pathological pressure on 3D-HTMCs, were daily measured up to 168 hrs, by 
Alamar Blue assay (Figure. 12). Therefore, the metabolic activity of 3D-HTMCs subjected 
to the pressure increase, shown a slightly decrease compared to the untreated 3D-HTMCs 
for all experimental time. 
 
Fig. 12. HTMC metabolic state. Metabolic state of untreated (UT) and pathological pressure treated 3D HTMCs 
cultured in dynamic conditions was analyzed by Alamar blue assay, after pathological pressure treatment. Data are 
expressed as “fold” Vs viability index of untreated 3D-HTMC, and each value represents the mean ± SD of 3 separate 
experiments running in triplicate. ***p <0.001 ;**p<0.01*;p<0.05; vs untreated 3D-HTMCs (Two-way ANOVA). 
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Confocal analysis  
In order to evaluate the morphological changes which occurred in the 3D-HTMC after 
increase of pressure, confocal analysis was performed at168 hrs. 
 
As known the F-actin bundles which constitute the microfilaments, under physiologic 
conditions regulate cell shape, phagocytosis, contraction, and motility. However, in 
glaucomatous TM the F-actin bundles are less linear and organized by giving a 
cytoskeleton disorganization.  
In Figure 13, in response to pathological pressure exposure, 3D-HTMC cell imaging 
reconstruction evidenced a different distribution of actin structure, nuclear size and an 
increased ECM, compared to 3D-HTMC cultures control.  
 
Fig.13: Morphological changes in 3D-HTMC cytoskeleton. Confocal microscopy analyses of nucleus and cytoskeletal 
markers were performed on 3D-HTMC cultures control and 3D-HTMC (A, and B, respectively) subjected to pathological 
pressure after 168 hours of experimental procedures. Representative images are related to immnuoreactivity for To-
ProTM and Phalloidin, as nuclear and cytoskeleton markers, respectively. Merged images shown cytoskeleton plus 
Nucleus. Fluorescence signals were captured at 60x magnification. 
  
A) B)
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qPCR analysis  
qPCR analysis for pro inflammatory, pro fibrotic and ECM remodeling markers was 
performed on 3D-HTMC at 72hrs of experimental conditions of increase of flow pressure, 
as mentioned above . 
The high pressure stimulated the mRNA expression of SPARC, COL1A1, -SMA, 
MYOC, TGFβ and also of TNFα, ILβ, MMP1 and MMP3. Indeed, this mechanical 
stimulus acts as important biological processes in ECM turnover and pro-inflammatory 
cytokines, and it be associated with TM fibrosis and cell function impairement (Figure. 14 
A,B,C,D) 
Western Blot Analysis 
NF-kB transactivation, as an inflammatory / antiapoptotic response marker, was analyzed 
in terms of the ratio between the levels of phospho-NF-kB p65, the activated form of NF-
kB, versus total NF-kB (Figure 14, E). A slightly increased of NF-kB activation occurred 
in 3D-HTMC undergone to pathological pressure. 
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Fig.14: ECM and pro-inflammatory cytokines gene regulations and NF-kB activation. Quantitative PCR gene 
expression analysis of 3D-HTMCs cultured dynamic conditions and subjected to. COL1A1, FN1, α-SMA, MYOC (A), 
MMP1, MMP3 and TIMP-1 (B), SPARC (C) IL-1α, IL-1, TNFα and TGFβ (D). Data are expressed as fold-increase 
relative to control at the same end-point and normalized to Ubiquitin housekeeping gene expression. Each bar represents 
the mean ± SD. of three independent experiments performed in triplicate. NF-kBp65 activation was evaluated in HTMC 
cells subjected to pathological pressure for 168 hrs. The analysis was performed by immunoblotting and the bars 
represent the ratio of phosfoNF-kBp65/NF-kBp65, and are expressed as fold vs. untreated HTMC cultures. Data 
represent the mean ± S.D. of 3 independent experiments. 
***p<0.001;**p <0.01;*p<0.05; vs untreated 3D-HTMCs (Two-way ANOVA). 
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Conclusions  
Our 3D-HTMC dynamic model with the Live Pa as auxillary device, was able to reproduce 
the main of pressure increase effects on TM cellular dysfunction which is the primary site 
of resistance to aqueous humor outflow [142]. Indeed, stimuli including mechanical stretch 
and/or OS damage, induce the the activation of TM signaling pathways which lead to 
several changes in ECM turnover, gene expression or the abnormal NF-κB family 
members expression [142–145]. Indeed it was reported that an excessive ECM deposition 
in TM, contributes to lost the IOP homeostasis. Therefore, the identification of factors 
involved in the dynamic balance of synthesis and degradation of ECM is of great 
importance, also at a pharmacological level [4,146]. 
As shown in Figure. 13, the mechanical stretch induced by increased pressure has 
determined in 3D-HTMC both the thickening of F-actin fibers and the cytoskeleton 
reorganization, compared to the F-actin structures and the organized cytoskeleton of 3D-
HTMC under normal dynamic conditions. 
Moreover, the molecular changes evoked by the increase of pressure in 3D-HTMC were 
analysed by several gene expression including MMPs which are necessary to maintain 
outflow facility and pro inflammatory and pro fibrotic markers. So, the ECM turnover in 
our model was sustained by the marked increase of MMP1 and MMP3 and by synergism 
between TNF-α and IL-1β up-regulation (Figure 14, D) [147]. However, the increase of 
SPARC amplification [146], that is a key factor in the ECM remodeling [148], promoted 
the activation of TGF-β signaling pathway and the COL1A1 up-regulation which have 
been identified as a possible pathogenic factor responsible for POAG [153,154]. 
In addition, it was given evidence that  the activation of inflammatory stress response via 
IL-1/NF-kappaB found in several forms of glaucoma, seems to be  regulated by a negative 
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feedback loop thought the endogenous MYOC over-expression [149]. Therefore, in our 
model the increase of pressure induced the MYOC up regulation without showing the 
effects of complete negative feedback loop because the NF-kB protein levels were 
significantly increased after 168hrs, compared to 3D-HTMC maintained under standard 
dynamic conditions (Figure. 14 A). 
Thus, we assumed that this pathological model described all the main features of TM 
dysfunction found in glaucomatous patients, after the increase of IOP. 
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3rd task:  Evaluation of the usefulness of the proposed in vitro 
platform to check the effectiveness of targeted therapies  
In order to assess the suitability of our milliluidic platform for screening efficacy of therapeutic 
approaches, we analysed the effects of a concentrated polyphenol mixture in counteracting 
the effects of OS and of flow pressure increase on dynamic 3D-HTMCs. The relevance of 
our 3D HTMC, in dynamic condition, with bioreactor system model as in vitro platform 
for assessing the efficacy of chemical drugs, we analysed the effects of a concentrated 
polyphenol mixture, after OS and increase of flow pressure. iTRAB® (Figure.15) is a 
patented formulation derived from Perilla extracts and it is a concentrated mixture of 
polyphenols ≥ 2.5%, with a high lipophilia and among its components there are catechins 
and fatty acids that are known to counteract the OS damage. In a previous study [74] 
iTRAB® was tested on 2D-HTMC model and it has been proven the antioxidant effects of 
compound with a directly controls the oxidative damage to TM and its high trans-corneal 
bio- availability. 
iTRAB® was tested on dynamic 3D-HTMC model under prolonged OS and under 
pathological pressure, two of the main POAG risk factors. 
 
MATERIALS AND METHODS  
3.1. Cell Cultures 
See paragraph 1.2.1 
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Fig.15. DRAIN drops® is an ophthalmic solution based on iTRAB® (high concentration polyphenols in hyaluronic acid) 
 
3.2. Experimental conditions 
The experimental working iTRAB ® solution was obtained by dissolving dry perilla 
extract in TMGM (0.15% final concentration, v/v), conforming to the informations of 
iTRAB® protocol 
Prolonged OS+ iTRAB®: 3D-HTMCs were daily treated for 2 hrs, in a static manner, 
with 500μM H2O2 (as already mentioned in the first part), then, after removal of the 
experimental medium, HTMC were exposed to iTRAB ® at the 0.15% in TMGM for 2 
hrs. Later the HTMCs  were cultured with the fresh media for further 20 hrs in dynamic 
conditions. 
Increased Flow Pressure + iTRAB®:3D-HTMC were submitted to IOP increase 
following the circadian rhythm for up to 72 hrs. After a daily complete pressure cycle, 
iTRAB ® working solution was added into culture, in a static manner, for 2 hrs. 
Subsequently, the cells were cultured with the fresh media for 22 hrs in dynamic 
conditions. 
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3.3. DCF Assay 
See paragraph 1.1.5 
3.4. Alamar Blue Assay 
See paragraph 1.2.4 
3.5.  qPCR Analysis 
See paragraph.1.2.5 . Primers used are shown in the Table 1. 
GENE GenBank  Forward  Reverse Size (bp) 
IL-1 NM_000575.4 CAATCTGTGTCTCTGAGTATC TCAACCGTCTCTTCTTCA 112 
MMP-1 NM_001145938.1 GGTGATGAAGCAGCCCAGATG CAGAGGTGTGACATTACTCCAGG 187 
MMP-3 NM_002422.5 TAATAATTCTTCACCTAAGTCTCT AGATTCACGCTCAAGTTC 99 
MMP-9 NM_004994.2 AACCAATCTCACCGACAGG CGACTCTCCACGCATCTC 85 
TNF NM_000594.4 GTGAGGAGGACGAACATC GAGCCAGAAGAGGTTGAG 95 
TGF-2 NM_001135599.3 AACCTCTAACCATTCTCTACTACA CGTCGTCATCATCATTATCATCA 149 
Alpha-SMA NM_001141945.1 TTGAGAAGAGTTACGAGTTG GGACATTGTTAGCATAGAGG 189 
Collagen 1A NM_000088.3 CTTTGCATTCATCTCTCAAACTTAGTTTT CCCCGCATGGGTCTTCA 163 
Myocilin NM_000261.2 GTTACCACAAGCCACAAT GAAGCATTAGAAGCCAACT 112 
Fibronectin 
(FN1) NM_002026 CCAgCAgAggCATAAggTTC 
ggTCAAAgCACgAgTCA
TCC 95 
Ubiquitin C NM_021009.7 ATTTGGGTCGCAGTTCTTG 
TGCCTTGACATTCTCGATGG
T 50 
Table 1. Primer sequences used for real time quantitative polymerase chain reaction analysis. 
3.6. Human Apoptosis Array 
See paragraph 1.1.8 
3.7. MTT Assay 
See paragraph 1.1.5 
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Results: Effects of ITRAB on OS  
 
DCF assay 
The fluorometric DCF assay was performed in order to evaluate the ability of hydrogen 
peroxide to induce ROS production in dynamic 3D-HTMC cultures and how the iTRAB® 
counteracts this production. The ROS production was quantified after 2 hrs with and 
without the addition of iTRAB® (Figure 16). A different ROS production after the 
addition of iTRAB® that’s clear: dynamic 3D-HTMC cultures decreased their intracellular 
ROS production by about 300 % 
 
 
Fig.16: DCF Assay. DCF assay were performed after 2 hrs of experimental procedures. Data are expressed as % of U.T. 
3D-HTMC and represent the mean ± SD of 3 indipendent experiments. ***p<0.001 vs UT; ### p< 0.001 vs H2O2 + 
iTRAB®. (Two-way ANOVA followed by Bonferroni’s test). 
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Alamar Blue Assay 
The effects of prolonged 500µM H2O2, iTRAB® and 500µM H2O2 + iTRAB® exposure 
on dynamic 3D-HTMC were measured at each check point time up to 72 hrs, by Alamar 
Blue assay (Figure. 17). 3D HTMC exposed to chronic stress reflected a decrease of 
resorufin reduction until 72 hrs. Conversely, untreated 3D HTMC cultures showed a 
constant increase of metabolic activities and even during iTRAB® treatment. Overall, at 
all time points,  the treated by 500µM H2O2 + iTRAB® 3D HTMCs evidenced an 
increase of their metabolic state as opposed to H2O2 exposure. This increment increased 
slightly after 72 hrs of treatment, whilst remaining lower than untreated cells. 
 
Fig.17: HTMC metabolic state.Viability indices were performed by Alamar blue assay.Data are expressed as Arbitrary 
units (AU). Each value represent the mean ± S.D of 2 separated experiments running in triplicate. ***p<0.001 Vs U.T.; § 
p<0.05 Vs H2O2 plus iTRAB® (Two-way ANOVA followed by Bonferroni’s test) 
  
24 48 72
0.0
0.2
0.4
0.6
0.8
1.0
U.T.
iTRAB
H2O2
H2O2+iTRAB*** ******
§
Time (Hours)
Vi
ab
ilit
y 
In
de
x 
(A
.U
.)
  
72 
 
qPCR analysis 
In order to evaluate the iTRAB® effects in countering the inflammatory stimulus of H2O2 
on dynamic 3D-HTMCs, the cells were treated for 72 h prior to performing inflammatory 
gene expression profiling. The gene expression levels of IL-1α, TNF-α, TGF-β and MMP-
1,3 and 9 were analysed by qPCR (Figure. 18A). At 72 hrs, the 3D-HTMCs treated with a 
pro-oxidant stimulus showed an increased of all cytokines compared to HTMCs untreated. 
Moreover, at this time point, 3D-HTMCs treated with iTRAB® revealed a slight, but 
significant decrease of pro-inflammatory cytokines. Also the TGF-β gene expression, a 
pro-fibrotic cytokines, decreased after treatment with iTRAB® compared to the 3D-
HTMCs treated with H2O2 (Figure.18B). 
Conversely, the MMP-1 MMP-3 gene expression showed a marked increase about 2 and 3 
fold respectively, after iTRAB® treatment compared to H2O2 3D-HTMC treatment 
(Figure.18C). 
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Fig.18. Gene expression. Quantitative PCR of IL1-α, TNF- α, TGF-β, MMP-1, MMP-3 and MMP-9 was performed at 
72 hrs. Data are expressed as fold-increase relative to U.T. at the same end-point and normalized to Ubiquitin 
housekeeping gene expression. Each bar represents the mean ± s.d. of three independent experiments performed in 
triplicate. ***p<0.001; **p<0.01; *p<0.05 vs U.T. ### p<0.001; ##p<0.01; #p<0.05 vs. H2O2 + iTRAB®(Two-way 
ANOVA followed by Bonferroni’s test)  
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Apoptosis Array 
After prolonged OS stress followed by iTRAB® treatment, multiple marker detection of 
apoptosis pathway was analyzed on dynamic 3D-HTMC models by a microarray for 
several pro-apoptotic proteins. In Figure.19 we reported only the levels of those anti-
apoptotic proteins that resulted in significant modulation. iTRAB® would seem capable to 
counteracting the apoptosis in dynamic 3D-HTMC model.  
 
 
Fig.19. Apoptosis array. Analysis of pro - apoptotic protein in 3D-HTMCs cultured in dynamic condition. In the 
graphs only the analysis of the markers significantly modulated were reported. Twelve individual models were 
arrayed (six static 3D-HTMCs plus six dynamic 3D-HTMC) and per experiment the intensity of Positive Control 
Spot was used to normalize signal responses for comparison of results across multiple arrays. ***p<0.001; **p<0.01; 
*p<0.05 vs U.T. ### p<0.001; ##p<0.01; #p<0.05 vs. H2O2 + iTRAB®(Two-way ANOVA followed by 
Bonferroni’s test). 
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3.8. Preliminary findings on effects of iTRAB® on oxidative stress 
In our experimental conditions the iTRAB administration after OS insult revealed:  
 antioxidant activity (AA) as demonstrated by DCF assay, which shown a marked 
intracellular ROS decrease about 300%; 
 counteraction of  the up-regulation of TNFα, TGF-β2, IL-1 cytokines; iTRAB up-
regulated the MMP1 and MMP3 expression which are important modulators of 
aqueous humor outflow. A decrease of MMPs leads to an accumulation of ECM in 
the outflow facilities and increases the aqueous humor outflow resistance; iTRAB 
reduced the pro-apoptotic protein levels.  
Then, iTRAB would seem capable to have a protective role on HTMCs against damage 
by OS. 
Recently, it has been reported that the antioxidant properties of polyphenols could exert a 
plethora of health benefits in a wide range of diseases, including glaucoma through 
different mechanisms of action [150]. So, the antioxidant properties have gained attention 
as active principle of anti-glaucomatous drugs.  
In particular, Saccà et al. (2019) have given evidence that  iTRAB displays antioxidant 
protective effects on TM cells [151] thanks to the presence of the 2,3-dihydroxy-4,6-
dimethoxychalcone which is an activator of the NRF2- antioxidant response element 
(ARE) pathway. Indeed, the NRF2 pathway activation plays a crucial role also in 
protecting RGCs from axonal damage [152,153]. Moreover, the iTRAB-polyunsaturated 
fatty acids (PUFAs) component posed by omega-3, down-regulates the inflammation 
cascade characteristic of glaucoma, dry eye macular degeneration [154].  
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Results: Increased Pressure flow and iTRAB® on dynamic 3D-
HTMC model. 
MTT assay and iTRAB® effects 
MTT assay was carried out as a ‘gold standard’ to evaluate cell viability by reference to the 
mitochondrial compartment functionality during IOP increase exposure (Figure. 20). After 
24 hrs of experimental treatment, the viability index of iTRAB®-treated HTMC revealed a 
slightly increase and it follows the trand of U.T. HTMCs at 48 and 72 hrs. However, 
during the experimental treatment with Live PA (IOP increase) and Live PA + iTRAB®, 
the mitochondrial functionality resulted impaired in the first experimental time and it 
restored after 72hrs of treatement with iTRAB®. 
 
Fig.20: HTMC Viability index. Viability indices were performed by MTT Assay. Data are expressed as Arbitrary Unit 
(AU). Each value represent the mean ± S.D. of two separated experiments running in triplicate. ***p<0.001; **p<0.01; 
*p<0.05 vs U.T. ###p<0.001; ##p<0.01; #p<0.05 vs H2O2 + iTRAB® (Two-way ANOVA followed by Bonferroni’s test) 
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qPCR analysis 
In order to evaluate the iTRAB® antifibrotic effect after with Live PA treatment on 3D-
HTMCs cultured in a dynamic manner, the cells were treated up to 72h. The gene 
expression levels of TGFβ, COL1A1, MYOC, α-SMA and FN1 were analyzed by qPCR 
(Figure. 21). At 72hrs Live PA-treated 3D-dynamic HTMCs showed a significantly 
marked up-regulation of TGFβ, COL1A1, MYOC, α-SMA and FN1 compared to untreated 
cultures, and their down-regulation, with gene expression levels equals to U.T. HTMCs, 
after the iTRAB® treatment. 
 
Fig.21: Gene expression. Quantitative PCR of TGF-β, COL1A1, MYOC, α-SMA and FN1 was performed at 72hrs. 
Data are expressed as fold-increase relative to U.T. at the same end-point and normalized to Ubiquitin housekeeping gene 
expression. Each bar represents the mean ± S.D. of three independent experiments performed in triplicate. ***p<0.001; 
**p<0.01; *p<0.05 vs U.T. ###p<0.001; ##p<0.01; #p<0.05 vs H2O2 + iTRAB® (Two-way ANOVA followed by 
Bonferroni’s test) 
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3.9.  Preliminary findings on effects of iTRAB® on increased pressure in 
dynamic 3D-HTMC model 
The iTRAB® administration during the increased flow pressure in the cell culture 
chamber, revelated that this compound counteract the up-regulation both of TGF-β, 
COL1A1, MYOC, α-SMA and FN1, involved in ECM regulation, confirming its anti-
fibrotic effect. 
Furthermore, several studies have demonstrated that elevated levels of TGF-beta are found 
in aqueous humor and in reactive optic nerve astrocytes in patients with glaucoma. Indeed, 
it is hypothesized that TGF-β affects extracellular matrix homeostasis and cell contractility 
in the TM through interactions with other proteins, by increasing out-flow resistance. In 
POAG, aqueous humor outflow resistance at the trabecular meshwork (TM) leads to 
increased intraocular pressure and RGCs death [61]. 
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Final Discussion 
Glaucoma is identified as the second cause of blindness in the world [6], characterized by a 
progressive loss of RGCs, in response to a currently major risk factor that is the high IOP 
[155]. The TM, in adult human eye, is a major tissue involved in the conventional 
acqueous humor outflow pathway and its the most sensitive tissue to oxidative stress (OS) 
damage [130]. 
Therefore, the TM cellular dysfunctions such as a decrease of TM mitochondrial 
respiratory activity, an impairment of extracellular matrix (ECM) components and its 
turnover, a cellular senescence promotion and a consequent loss of its cellularity, and so on 
[52,156], cause an outflow resistance. Moreover, it has been hypothesized that the 
glaucomatous suffering of TM cells (TMCs) affects their gene and protein expression 
generating those molecular signals which, from anterior to posterior chamber, reach the 
head of the optic nerve contributing to the RGCs death [157]. 
 
The studies of TM behavior has helped to understand the pathophysiology of glaucoma: 
several researches has been based on animal experimentation, but the animal models 
present many disadvanteges due to the difference of tissue anatomy [79,80]. 
However, the 2D-HTMC in vitro model is a viable option to understand the TM behavior 
[148,158], but in our previous study [119] we gave evidence of the suitability of 3D- 
HTMC cultures for assessing a more realistic model than 2D-model. To further improve 
the cell environments and consequently, to create a condition “closer to in vivo”, we 
applied the millifluidic technique to 3D HTMC culture. In our 3D-HTMC model the 
HTMCs were embedded in Matrigel ®, that its consists of structural and organizational 
ECM components: laminin, collagen IV, heparan sulfate proteoglycan and 
entactin/nidogen [159], so with the Matrigel ® has been recreated in vitro an appropriate 
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microenvironment for the development of 3D-HTMC cultures, as demonstrated by 
Bouchemi et al., 2017 [155].  
At the end of our studies, it was provided the evidence that our model maintained the tissue 
architecture polarity which represents an important hallmark for the tissue function 
maintenance found in vivo. Indeed, the cellular polarization preservation sustained a long-
term viability of the cells showing the modulation of apoptosis markers and NF-kB protein 
levels in favor of an efficient adaptive response over time to OS-damage [160] with the 
trigger of the inflammation cascade instead of cell death (figure 7-8 chapter 1.2). 
Moreover, in a more suitable habitat the cells into dialogue with each other, by promoting 
cell survival and proliferation in a more realistic manner even after stimuli, such as 
oxidative stress. 
Therefore, in our study the dynamic 3D-HTMC model turns out to be a useful tool to 
identify key events of glaucoma damage onset, and its long term complications, by 
mimicking tissue- cross talk with other tissue, joining different modeles/chambers in 
series. In this manner, it is possible analyze step-by-step the stage of cell damage which 
underlie glaucoma and its adverse outcomes. 
 
In conclusion, to validate our dynamic 3D-HTMC model we have tested the protective 
effect of the iTRAB®after the OS condition and the increase of culture chamber pressure. 
So, regarding iTRAB activity on 3D HTMC damaged by OS, has been shown a very 
significant difference in intracellular ROS production after 4hrs of experimental 
conditions, confirming its anti-oxidative role. The anti-inflammatory and anti-fibrotic 
effects of iTRAB were demonstrated by the significant reduction in IL-α, TNF-α and TGF-
β cytokine profile, compared to 3D HTMC treated only by oxidative stress condition. 
Moreover, the iTRAB ability in remodeling the trabecular meshwork extracellular matrix 
composition to maintain a stable outflow resistance, was explained by the MMP1 and 
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MMP3 up-regulation [161]. At last, the iTRAB anti-apoptotic effect has been proven by 
apoptosis array which shown a marked difference in pro-apoptotic protein levels, 
compared both untreated 3D HTMC and 3D HTMC treated only by oxidative stress.  
These results are in line with experimental evidence which highlighted the protective role 
of polyphenols [162].  
The iTRAB was effective also against the mechanical stretch induced by the increase of 
culture chamber pressure. Indeed, the gene down-regulation of TGf-β and several genes 
involved in ECM turnover, confirmed its anti-fibrotic effect.  
So, we can conclude that our in vitro advanced 3D model is useful to increase the iTRAB 
intracellular bioavailability in a physiological and safe manner and to study its 
therapeutical properties on damaged TM cells.  
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